These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 24062506)
1. Comment on 'Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism': author's response. Bitzer J J Fam Plann Reprod Health Care; 2013 Oct; 39(4):304-5. PubMed ID: 24062506 [No Abstract] [Full Text] [Related]
2. Comment on 'Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism'. Terplan M; Zuckerman D J Fam Plann Reprod Health Care; 2013 Oct; 39(4):304. PubMed ID: 24062505 [No Abstract] [Full Text] [Related]
3. Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism. Bitzer J; Amy JJ; Beerthuizen R; Birkhäuser M; Bombas T; Creinin M; Darney PD; Vicente LF; Gemzell-Danielsson K; Imthurn B; Jensen JT; Kaunitz AM; Kubba A; Lech MM; Mansour D; Merki G; Rabe T; Sedlecki K; Serfaty D; Seydoux J; Shulman LP; Sitruk-Ware R; Skouby SO; Szarewski A; Trussell J; Westhoff C J Fam Plann Reprod Health Care; 2013 Jul; 39(3):156-9. PubMed ID: 23585363 [No Abstract] [Full Text] [Related]
4. Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism. Bitzer J; Amy JJ; Beerthuizen R; Birkhäuser M; Bombas T; Creinin M; Darney PD; Vicente LF; Gemzell-Danielsson K; Imthurn B; Jensen JT; Kaunitz AM; Kubba A; Lech MM; Mansour D; Merki G; Rabe T; Sedlecki K; Serfaty D; Seydoux J; Shulman LP; Sitruk-Ware R; Skouby SO; Szarewski A; Trussell J; Westhoff C Eur J Contracept Reprod Health Care; 2013 Jun; 18(3):143-7. PubMed ID: 23578274 [No Abstract] [Full Text] [Related]
5. Type of Combined Contraceptives, Factor V Leiden Mutation and Risk of Venous Thromboembolism. Hugon-Rodin J; Horellou MH; Conard J; Gompel A; Plu-Bureau G Thromb Haemost; 2018 May; 118(5):922-928. PubMed ID: 29614525 [TBL] [Abstract][Full Text] [Related]
9. The state of hormonal contraception today: benefits and risks of hormonal contraceptives: combined estrogen and progestin contraceptives. Shulman LP Am J Obstet Gynecol; 2011 Oct; 205(4 Suppl):S9-13. PubMed ID: 21961825 [TBL] [Abstract][Full Text] [Related]
10. Specific oral contraceptive use and venous thromboembolism resulting in hospital admission. Heuser P; Tonga K; Hopkins R; Henderson M; Weatherall M; Metcalfe S; Beasley R N Z Med J; 2004 Nov; 117(1206):U1176. PubMed ID: 15570345 [TBL] [Abstract][Full Text] [Related]
11. [Peroral hormonal contraception and risk of venous thromboembolism]. Ludka O; Spinar J; Musil V; Pozdísek Z Vnitr Lek; 2010 May; 56(5):370-5. PubMed ID: 20578585 [TBL] [Abstract][Full Text] [Related]
12. [Diffuse symptoms in young women may indicate venous thromboembolism. Important to ask about the use of combined hormonal contraception]. Milsom I; von Sydow H; Thörn AB; Björkelund C; Odlind V Lakartidningen; 2012 Sep 19-26; 109(38):1680-2. PubMed ID: 23094400 [No Abstract] [Full Text] [Related]
13. Pharmacodynamics of combined estrogen-progestin oral contraceptives: 2. effects on hemostasis. Farris M; Bastianelli C; Rosato E; Brosens I; Benagiano G Expert Rev Clin Pharmacol; 2017 Oct; 10(10):1129-1144. PubMed ID: 28712325 [TBL] [Abstract][Full Text] [Related]
14. Combined hormonal contraceptives and venous thromboembolism: putting the risks into perspective. Raymond EG; Burke AE; Espey E Obstet Gynecol; 2012 May; 119(5):1039-44. PubMed ID: 22525916 [TBL] [Abstract][Full Text] [Related]
15. Does the Progestogen Used in Combined Hormonal Contraception Affect Venous Thrombosis Risk? Han L; Jensen JT Obstet Gynecol Clin North Am; 2015 Dec; 42(4):683-98. PubMed ID: 26598309 [TBL] [Abstract][Full Text] [Related]
16. Risk of recurrent venous thromboembolism on progestin-only contraception: a cohort study. Le Moigne E; Tromeur C; Delluc A; Gouillou M; Alavi Z; Lacut K; Mottier D; Le Gal G Haematologica; 2016 Jan; 101(1):e12-4. PubMed ID: 26452982 [No Abstract] [Full Text] [Related]
17. Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis. Martínez F; Ramírez I; Pérez-Campos E; Latorre K; Lete I Eur J Contracept Reprod Health Care; 2012 Feb; 17(1):7-29. PubMed ID: 22239262 [TBL] [Abstract][Full Text] [Related]
18. Combined hormonal contraception and the risk of venous thromboembolism: a guideline. ; Fertil Steril; 2017 Jan; 107(1):43-51. PubMed ID: 27793376 [TBL] [Abstract][Full Text] [Related]
19. [Cardiovascular risks of combined oral contraceptives - beyond the French controversy]. Gronier H; Robin G Gynecol Obstet Fertil; 2014 Mar; 42(3):174-81. PubMed ID: 24582295 [TBL] [Abstract][Full Text] [Related]
20. [Venous thromboembolism and oral contraception]. Veljković M; Popovć J Med Pregl; 2010; 63(5-6):376-9. PubMed ID: 21186550 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]